2012 Midyear Clinical Meeting
Click here to go to the previous page
Evidence Based Approaches to Pharmacokinetic Dilemmas 2012
Track:
Education Sessions (CE)
Program Code: 227-L04
Date: Wednesday, December 5, 2012
Time: 2:30 PM to 4:30 PM EST
Location:
Breakers C, Level 2, South Convention Center
PRESENTER(S):
Click the plus sign to see more detailed information about each speaker.
Thomas Dowling,
PharmD, PhD, Associate Professor and Vice Chair,
University of Maryland
|
Dr. Thomas Dowling is Associate Professor and Vice Chair in the Department of Pharmacy Practice and Science at the University of Maryland. He received his PharmD degree from Ferris State University, completed a residency in pharmacy practice at the University of Maryland Medical Center, and obtained a PhD in Clinical Pharmaceutical Sciences from the University of Pittsburgh. Over the past 15 years he has conducted clinical and translational research in nephrology and pharmacokinetics funded by the NIH, FDA, AFPE, ACCP, NKF and the pharmaceutical industry. He has authored over 40 manuscripts in journals such as Pharmacotherapy, Clinical Pharmacology and Therapeutics, and Circulation, along with book chapters in John Murphy's Clinical Pharmacokinetics, and DiPiro's Pharmacotherapy.
|
Mary Ensom,
PharmD, FCCP, Professor,
University of British Columbia
|
Dr. Mary Ensom (formerly Chandler) is Professor, Faculty of Pharmaceutical Sciences and Distinguished University Scholar, University of British Columbia (UBC) and Clinical Pharmacy Specialist, Children's & Women's Health Centre of British Columbia.
She earned her B.S. (Pharm.) degree (1977) and Pharm.D. (1985), both from the University of Kentucky (UK). In between degrees, she was a hospital pharmacist and developed clinical services in South Carolina, Washington, and Kentucky. She completed a 2-year postdoctoral fellowship in Clinical Pharmacokinetics at the UK College of Pharmacy in 1987, served on the faculty there and also as Director of the Clinical Pharmacokinetics Service at the UK Chandler Medical Center for 10 years (1987-97) before joining the Faculty at UBC in 1997.
Dr. Ensom's long-term research interests have been in clinical pharmacokinetics and pharmacodynamics with more recent interests in pharmacogenetics and pharmaceutical outcomes evaluations. She has ~450 publications to her credit. In addition to 9 outstanding teacher awards (including the 2011 ACCP Education Award), Dr. Ensom has received ~60 other awards for scholarship, service and research (including the 2006 ACCP Publication Award and 2007 UBC Killam Research Prize in Science). She is Editor for the Canadian Journal of Hospital Pharmacy and serves on editorial boards of 5 other international journals. She is a fellow of ASHP, ACCP, CSHP, and the Canadian Academy of Health Sciences, Canada's equivalent to the Institute of Medicine.
|
John Murphy,
PharmD, FCCP, Professor and Associate Dean,
The University of Arizona College of Pharmacy
|
John E. Murphy, PharmD, FASHP, FCCP, is Professor of Pharmacy Practice and Science and Associate Dean for Professional and Academic Affairs at the College of Pharmacy, and Professor of Family and Community Medicine at the College of Medicine, the University of Arizona in Tucson. He is also an Honorary Professor at the University of Otago School of Pharmacy in Dunedin, New Zealand. John received BS in pharmacy and PharmD degrees from the University of Florida in Gainesville, where he was a recipient of the Distinguished Pharmacy Alumnus Award in 1998.
Long active in pharmacy organizations, Dr. Murphy was most recently president of the American College of Clinical Pharmacy (2008-2009) as well as president of the American Society of Health-System Pharmacists (1997-1998) and of the Georgia Society of Hospital Pharmacists.
Dr. Murphy has published over 200 papers, ~ 100 abstracts, five editions of Clinical Pharmacokinetics, the Resident Survival Guide, and is a frequent speaker at international, national, and statewide continuing education meetings.
|
Michael Winter,
PharmD, Professor Emeritus,
University of California, San Francisco, School of Pharmacy
|
Dr. Michael Winter is a Professor Emeritus in the Department of Clinical Pharmacy, School of Pharmacy at the University of California at San Francisco. Dr. Winter joined the faculty in 1970 and served as Vice Chair in the Department from 1984 until his retirement in 2007. He continues to be active in the Department and provides clinical consultation to health care providers for patients with complex pharmacokinetic problems. In addition he lectures, guides conferences and leads workshops at the local, state, national and international level on the use of pharmacokinetics in the patient care setting. He is the author of Basic Clinical Pharmacokinetics as well as other articles and book chapters on clinical pharmacokinetics. He is a Fellow in the California and American Society of Health-Systems Pharmacists and is active in professional associations at the local, state and national level
|
PROGRAM CHAIR:
Click the plus sign to see more detailed information about each speaker.
John Murphy,
PharmD, FCCP, Professor and Associate Dean,
The University of Arizona College of Pharmacy
|
John E. Murphy, PharmD, FASHP, FCCP, is Professor of Pharmacy Practice and Science and Associate Dean for Professional and Academic Affairs at the College of Pharmacy, and Professor of Family and Community Medicine at the College of Medicine, the University of Arizona in Tucson. He is also an Honorary Professor at the University of Otago School of Pharmacy in Dunedin, New Zealand. John received BS in pharmacy and PharmD degrees from the University of Florida in Gainesville, where he was a recipient of the Distinguished Pharmacy Alumnus Award in 1998.
Long active in pharmacy organizations, Dr. Murphy was most recently president of the American College of Clinical Pharmacy (2008-2009) as well as president of the American Society of Health-System Pharmacists (1997-1998) and of the Georgia Society of Hospital Pharmacists.
Dr. Murphy has published over 200 papers, ~ 100 abstracts, five editions of Clinical Pharmacokinetics, the Resident Survival Guide, and is a frequent speaker at international, national, and statewide continuing education meetings.
|
Description
Generic Substitution of Antiepileptic Drugs is a Safe Practice, Michael E. Winter, PharmD, FASHP
The MDRD Equation Should Replace Cockroft-Gault for Determining Doses of Drugs in Renal Dysfunction, Thomas C. Dowling, PharmD, PhD
Pharmacokinetic Drug-Drug Interactions are Mostly of Theoretical Rather Than Practical Importance to Patient Safety, John E. Murphy, PharmD, FCCP, FASHP
The Best Size Descriptor for Drug Dosing in Obese Patients is not Ideal Body Weight as Determined by the Devine Method, Mary Ensom, PharmD, FCCP, FASHP
- Describe debates in the literature on the use of weight estimates for drug dosing.
- Discuss controversial issues in the literature related to generic substitution of anti-epileptic drugs.
- Evaluate the use of the MDRD equation for dosing medications in the presence of diminished renal function.
- Identify issues about the pharmacokenetics of drug-drug interactions.
